Live Breaking News & Updates on Dr Reddy Amp 039s Laboratories|Page 2

Stay updated with breaking news from Dr reddy amp 039s laboratories. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Coronavirus: On Request For Sputnik 5 Vaccine Approval, Subject Expert Committee Seeks More Data From Dr Reddy's Laboratories: Sources


The Sputnik vaccine has an efficacy of 91.6 per cent.
New Delhi:
The Subject Expert Committee (SEC) of the Indian drug regulator has asked pharma giant Dr Reddy s Laboratories, the Indian manufacturer of Sputnik V, the Russia-developed coronavirus vaccine, for more data regarding its application for emergency use approval for the vaccine, sources said.
Dr Reddy s Laboratories had approached the Drug Controller General of India (DGCI) on February 19 to get approval for the emergency use of Sputnik V. The vaccine has an efficacy of 91.6 per cent.
On Wednesday, the company presented the safety data of the second phase of trials and the interim data of the third phase during the meeting with the expert panel. Sources said the panel, after reviewing the application, asked the firm to provide some additional details, including immunogenicity and safety data. ....

Oxford Astrazeneca Covishield , Panel Seeks More Data , Expert Committee , Serum Institute Of India , Russian Direct Investment Fund , Request For Sputnik , Subject Expert Committee , Drug Controller General , While Oxford Astrazeneca , Serum Institute , Bharat Biotech , Corona Virus , Dr Reddy Amp 039s Laboratories , நிபுணர் குழு , சீரம் நிறுவனம் ஆஃப் இந்தியா , ரஷ்ய நேரடி முதலீடு நிதி , கோரிக்கை க்கு ஸ்பட்நிக் , பொருள் நிபுணர் குழு , மருந்து கட்டுப்படுத்தி ஜநரல் , சீரம் நிறுவனம் , பாரத் பயோடெக் , கொரோனா வைரஸ் ,

Coronavirus: Sputnik 5 Vaccine, Efficacy 91.6 Per Cent, For India? Meeting Today To Review


The Sputnik vaccine has an efficacy of 91.6 per cent.
Highlights
Russia-developed shot has higher efficacy than ones being used in India
In India, the trials are being conducted on 1,600 people
New Delhi:
The Subject Expert Committee (SEC) of the Indian drug regulator will meet today to take up an application by pharma giant Dr Reddy s Laboratories seeking emergency approval for Sputnik V, the Russia-developed coronavirus vaccine. The vaccine has an efficacy of 91.6 per cent.
On February 19, Dr Reddy s Laboratories had approached the Drug Controller General of India (DGCI) to get approval for the emergency use of Sputnik V.
At 91.6 per cent, Sputnik V has a higher efficacy as compared to Covid vaccines that are currently being administered in India. While Oxford-AstraZeneca s Covishield vaccine, being manufactured by the Serum Institute of India, has an efficacy of around 70 per cent, Bharat Biotech s Covaxin s efficacy is not known. ....

New Delhi , Oxford Astrazeneca Covishield , Expert Committee , Serum Institute Of India , Russian Direct Investment Fund , Subject Expert Committee , Drug Controller General , While Oxford Astrazeneca , Serum Institute , Bharat Biotech , Sputnik V , Coronavirus Vaccine , Dr Reddy Amp 039 S , Dr Reddy Amp 039s Laboratories , புதியது டெல்ஹி , நிபுணர் குழு , சீரம் நிறுவனம் ஆஃப் இந்தியா , ரஷ்ய நேரடி முதலீடு நிதி , பொருள் நிபுணர் குழு , மருந்து கட்டுப்படுத்தி ஜநரல் , சீரம் நிறுவனம் , பாரத் பயோடெக் , ஸ்பட்நிக் வ் ,